IBULEVE

This brand name is authorized in Israel, United Kingdom, South Africa

Active ingredients

The drug IBULEVE contains one active pharmaceutical ingredient (API):

1 Ibuprofen UNII WK2XYI10QM - IBUPROFEN

Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation. Read about Ibuprofen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IBULEVE Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M02AA13	Ibuprofen	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 134503, 146959, 169682, 183771, 22830, 22831, 22832, 22833
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3325
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/3.1/0086